Clinical effect and affecting factors of trastuzumab and pertuzumab dual target combined with chemother-apeutic drug in neoadjuvant therapy of human epidermal growth factor receptor-2 positive breast cancer

Liu Heng; Li Xiunan; Wang Gangyue

doi:10.3760/j.issn.1673-4777.2023.10.017

Home>Articles>Clinical effect and affecting factors of trastuzumab and pertuzumab dual target combined with chemother-apeutic drug in neoadjuvant therapy of human epidermal growth factor receptor-2 positive breast cancer

DOI: 10.3760/j.issn.1673-4777.2023.10.017

Clinical effect and affecting factors of trastuzumab and pertuzumab dual target combined with chemother-apeutic drug in neoadjuvant therapy of human epidermal growth factor receptor-2 positive breast cancer

Liu Heng

Li Xiunan

Wang Gangyue

Keywords：Breast cancerHuman epidermal growth factor receptor-2 positiveNeoadjuvant therapyTrastuzumabPertuzumab

Publication Date：2023-10-08

Online Publishing Date：2026-09-14(First online date of this platform, not the publication date of the document)

Pages：5( 1517-1521 )

China Medicine

ISTIC

ISSN：1673-4777

Year, Vol.(Issue)：2023,18(10)